USFDA conducts records assessment of Dr Reddy’s Mexico facility, issues 2 observations
New Delhi: Pharmaceutical major Dr Reddy’s Laboratories on Friday said the US health regulator has conducted a records assessment of its active pharmaceutical ingredient (API) manufacturing facility in Mexico and issued two observations. The assessment at the facility — Industrias Químicas Falcon de México, SA de CV (Dr Reddy’s Laboratories Ltd) — has been completed…
